Učitavanje...
Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada
IMPORTANCE: Cancer drugs approved by the US Food and Drug Administration have come under scrutiny for marginal clinical benefits; however, the clinical benefits of cancer drugs recommended for reimbursement in Canada have not been adequately studied. OBJECTIVE: To assess the differences in the clini...
Spremljeno u:
| Izdano u: | JAMA Intern Med |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Medical Association
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7900938/ https://ncbi.nlm.nih.gov/pubmed/33616606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.8588 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|